Condition: Focal Drug-resistant Epilepsy · Sponsor: Assistance Publique - Hôpitaux de Paris
The TIPI2 study is a blood and tissue collection protocol to create an annotated biorepository to support research in drug-resistant epilepsy. The aim of the study will be to identify new pathophysiological pathways. For this purpose, the investigators will investigate with a multimodal approach blood and brain samples from patients undergoing a surgery for focal drug-resistant epilepsy. The adult patients will be enrolled either during the pre-surgical evaluation or right before the surgery.
This description comes directly from the study's public registry record.
Vincent M. Navarro, MD, PHD · 01 42 16 19 40 · Vincent.navarro@aphp.fr
Aurélie Ms Hanin, PharmD, PhD · 01 57 27 40 56 · Aurelie.hanin@icm-institute.org
Always discuss trial participation with your own doctor first.
| Department of Neurology, Epilepsy Unit, Pitié-Salpêtrière Hospital | Paris, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06022055